FDA Inspection
Eversight IllinoisEversight Illinois – FDA Inspection, Jun 18, 2024
Record Details
This FDA Inspection record concerns Eversight Illinois, with an inspection on June 18, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · bcb4d369-162e-4484-8bcd-d4a62c2666d9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241628
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eversight Illinois
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 9, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 18, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 19, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 3, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Eversight Illinois
- FDA Inspection 1055320 - 2018-04-18
- FDA Inspection 968460 - 2016-05-09
- FDA Inspection 883885 - 2014-06-18
- FDA Inspection 759437 - 2011-12-19
- FDA Inspection 634088 - 2009-12-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.